Showing results (291-300 of 388) with videos related to
Sort By:
Pageof 39
Plos One|September 23, 2025
Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical noteAnna-Laura Potthoff, Meng-Chun Hsieh, Ahmad Melhem, et al.Neuro-Oncology|October 11, 2017
Diffuse high-grade gliomas with H3 K27M mutations carry a dismal prognosis independent of tumor locationMichael Karremann, Gerrit H Gielen, Marion Hoffmann, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 5, 2010
Phase I/IIa study of cilengitide and temozolomide with concomitant radiotherapy followed by cilengitide and temozolomide maintenance therapy in patients with newly diagnosed glioblastomaRoger Stupp, Monika E Hegi, Bart Neyns, et al.Neuro-Oncology Advances|December 23, 2024
Impact of molecular classification on prognosis in children and adolescents with spinal ependymoma: Results from the HIT-MED databaseLara Engertsberger, Martin Benesch, Martin Mynarek, et al.Journal for Immunotherapy of Cancer|October 2, 2021
Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumorsAna Marcu, Andreas Schlosser, Anne Keupp, et al.Ebiomedicine|August 30, 2020
Molecular, clinicopathological, and immune correlates of LAG3 promoter DNA methylation in melanomaAnne Fröhlich, Judith Sirokay, Simon Fietz, et al.Nature Communications|May 28, 2024
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy in newly-diagnosed glioblastoma: dose escalation of the phase I/II GLORIA trialFrank A Giordano, Julian P Layer, Sonia Leonardelli, et al.The Journal of Clinical Investigation|April 10, 2008
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomasStefan Pfister, Wibke G Janzarik, Marc Remke, et al.Acta Neuropathologica|January 22, 2021
Supratentorial ependymoma in childhood: more than just RELA or YAPValentina Zschernack, Stephanie T Jünger, Martin Mynarek, et al.Neuro-Oncology|July 3, 2016
Long-term analysis of the NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with PCV or temozolomideWolfgang Wick, Patrick Roth, Christian Hartmann, et al.Pageof 39